X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/neurophth-announces-completion-of-patient-enrollment-for-opvika-phase-iii-clinical-trial-in-the-us-302064859.html
https://www.prnewswire.com/news-releases/neurophth-announces-first-patient-dosed-in-phase-iii-clinical-trial-of-second-gene-therapy-301903288.html
https://www.contractpharma.com/contents/view_breaking-news/2023-08-14/neurophth-secures-95m-in-series-c-financing-for-gene-therapy-clinical-trials/?widget=listSection
https://www.prnewswire.com/news-releases/commercialization-of-gene-therapy-is-coming-soon-neurophth-completes-patient-enrollment-for-phase-iii-clinical-trial-for-the-gene-therapy-treatment-of-lhon-301751494.html
https://www.prnewswire.com/news-releases/neurophth-receives-ind-clearance-from-fda-for-aav-nd1-gene-therapy-of-lhon-301705927.html
https://www.pharmaceutical-technology.com/news/cyagen-neurophth-gene-therapy/
https://www.prnewswire.com/news-releases/china-cde-grants-breakthrough-therapy-designation-btd-to-neurophths-nr082-in-lhon-301587402.html
https://www.prnewswire.com/news-releases/neurophth-therapeutics-treatment-of-lebers-hereditary-optic-neuropathy-gene-therapy-nr082-was-granted-orphan-drug-designation-by-ema-301467123.html
https://www.prnewswire.com/news-releases/neurophth-therapeutics-receives-ind-clearance-to-initiate-clinical-trial-for-china-aav-nd4-gene-therapy-nr082-in-leber-hereditary-optic-neuropathy-301462517.html
https://www.prnewswire.com/news-releases/neurophth-raised-over-60-million-usd-in-series-c-financing-to-advance-gene-therapies-301430485.html
Market Place
Share 
